In particular, NUP155 expression was upregulated in immune cells, especially in proliferative T cells (T prolif cells), Treg cells, and CD8 + exhausted T (Tex) cells, of patients with CRC, LIHC, SKCM, and NSCLC (Supplementary Fig. 6). Here, NUP155 is linked to colorectal carcinoma.